by Mathilde GRAAS | May 22, 2026
EFCG, the European Fine Chemicals Group representing the European manufacturers of fine chemicals including Active Pharmaceutical Ingredients (APIs), excipients and intermediates, welcomes the European Commission’s communication on “Reinforcing global health...
by Anais FANTASIA | May 19, 2026
The European Fine Chemicals Group (EFCG), a sector group of Cefic representing the European manufacturers of fine chemicals including Active Pharmaceutical Ingredients (APIs), drug substances, excipients and intermediates, supports a strong Biotech Act I that...
by Mathilde GRAAS | May 13, 2026
The European Fine Chemicals Group (EFCG) welcomes the provisional agreement reached between the European Council and the European Parliament on the Critical Medicines Act (CMA) on 12 May 2026. This agreement represents a key milestone in strengthening Europe’s...
by Anais FANTASIA | Nov 19, 2025
Europe faces a pivotal moment in its ability to provide essential medicines to its citizens. The Critical Medicines Act (CMA) was designed as a transformative policy to address recurring shortages and reduce dependency on non-EU suppliers. However, current legislative...
by Anais FANTASIA | Apr 29, 2024
